Apr 2022

PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy

Toscano A, Cinquegrani M, Scuruchi M, et al.

First published: April 9, 2022  DOI: 10.3390/biom12040562